Desiree M. Van Oorschot
Waver, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Prevalence of Respiratory Syncytial Virus in Adult Patients with Respiratory Illnesses in Low to Middle-Income Countries: A Systematic Review and Meta-Analyses.
Journal: Infectious diseases and therapy
Published: August 14, 2025
Public health impact of adjuvanted RSVPreF3 vaccine in older adults: a modeling study in nine countries in Middle East and North Africa.
Journal: Expert review of vaccines
Published: July 28, 2025
Public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in six Latin American countries.
Journal: Expert review of vaccines
Published: July 28, 2025
Potential public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in India and Southeast Asia.
Journal: Expert review of vaccines
Published: June 20, 2025
Respiratory Syncytial Virus Epidemiology and Clinical Burden in High-Risk and ≥ 50-Year-Old Adults in Low- to Middle-Income Countries: An Artificial-Intelligence-Enabled Systematic Literature Review.
Journal: Infectious diseases and therapy
Published: June 09, 2025
The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts' Network Scientific Workshop.
Journal: Vaccines
Published: October 16, 2024
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries.
Journal: Infectious disease reports
Published: June 10, 2024
Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model.
Journal: Value in health regional issues
Published: January 30, 2024
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia.
Journal: Infectious diseases and therapy
Published: December 15, 2023
Assessing the Underestimation of Adult Pertussis Disease in Five Latin American Countries.
Journal: Infectious diseases and therapy
Published: September 15, 2023
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.
Journal: Human vaccines & immunotherapeutics
Published: June 20, 2023
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Journal: Human vaccines & immunotherapeutics
Published: February 23, 2023
Last Updated: 09/26/2026